Lymphoma, T-Cell - 42 Studies Found
| Not yet recruiting |
: 18F-FDG PET/CT-based Prognostic Model for Predicting Outcome in Patients With Peripheral T-cell Lymphoma : Lymphoma, T-Cell, Peripheral : 2017-02-09 : Device: 18F-FDG PET/ CT 18F-FDG PET/CT will be conducted before, during and after chemotherapy. Patients |
| Not yet recruiting |
: Evaluating 18F-FDG PET/CT With Liver SUVmax-based Criteria for Prognosis of Patients With Peripheral T-cell Lymphoma : Lymphoma, T-Cell, Peripheral : 2017-02-09 : Device: 18F-FDG PET/CT 18F-FDG PET/CT will be conducted before, during and after chemotherapy. Patients |
| Completed |
: Safety, Pharmacodynamics (PD), Pharmacokinetics (PK) Study of SHP141 in 1A, 1B, or 2A Cutaneous T-Cell Lymphoma (CTCL) : Lymphoma, T-Cell, Cutaneous : 2011-09-09 :
|
| Completed |
: Clinical Study of Chemoradiation Followed by VIPD in Nasal Natural Killer (NK)/T-cell Lymphoma : Lymphoma, T-Cell : 2007-01-03 : Drug: Concurrent Radiotherapy (RT)/cisplatin, VIPD |
| Completed |
: Study of ONTAK® to Treat Cutaneous T-Cell Lymphoma (CTCL) : Lymphoma, T-Cell, Cutaneous : 2005-09-13 : Drug: ONTAK (denileukin difitox, DAB389IL-2) |
| Recruiting |
: T-Cell Project: Prospective Collection of Data in Patients With Peripheral T-Cell Lymphoma : Lymphoma, T-Cell, Peripheral : 2010-06-10 |
| Recruiting |
: Alemtuzumab and CHOP in T-cell Lymphoma : Lymphoma, T-Cell, Peripheral : 2008-02-14 :
|
| Active, not recruiting |
: Open-label, Phase II Study of MLN9708 in Patients With Relapsed/Refractory Cutaneous and Peripheral T-cell Lymphomas : Lymphoma, T-Cell : 2014-06-05 : Drug: MLN9708 |
| Completed |
: A Study of the Histone Deacetylase Inhibitor (HDACi) Quisinostat (JNJ-26481585) in Patients With Previously Treated Stage Ib-IVa Cutaneous T-cell Lymphoma : Lymphoma, T-Cell, Cutaneous : 2011-11-29 : Drug: Quisinostat, 12 mg Participants will receive quisinostat 12 mg capsule orally (by mouth) on Days 1 |
| Completed |
: CPG 7909 in Patients With Cutaneous T-Cell Lymphoma : Lymphoma, T-Cell, Cutaneous : 2002-08-08 :
|